Validation of IDSA/ATS Algorithm for Duration of Pneumonia Therapy
Werner C. Albrich(University of St.Gallen), Angela Huttner(University Hospital of Geneva), Benedikt Huttner(World Health Organization)
Cited by 0
Related Papers
The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistance
|The Lancet Infectious Diseases|2025|526
Antimicrobial resistance: a global view from the 2013 World Healthcare-Associated Infections Forum
|Antimicrobial Resistance and Infection Control|2013|454
How to use biomarkers of infection or sepsis at the bedside: guide to clinicians
|Intensive Care Medicine|2023|293
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial
|The Lancet Infectious Diseases|2015|278
The <i>WHO AWaRe (Access, Watch, Reserve) antibiotic book</i> and prevention of antimicrobial resistance
|Bulletin of the World Health Organization|2023|276